ID

14780

Descrizione

A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01); ODM derived from: https://clinicaltrials.gov/show/NCT00520637

collegamento

https://clinicaltrials.gov/show/NCT00520637

Keywords

  1. 27/04/16 27/04/16 -
Caricato su

27 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Advanced Solid Tumors NCT00520637

Eligibility Advanced Solid Tumors NCT00520637

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
Descrizione

solid tumor or lymphoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0280100
UMLS CUI [2]
C0024299
measurable or evaluable disease
Descrizione

measurable or evaluable disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
score of 0 to 2 on the ecog performance scale
Descrizione

ecog

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent serious medical illness
Descrizione

medical illness

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0262926
known, clinically suspected, or history of central nervous system (cns) tumor involvement
Descrizione

central nervous system (cns) tumor involvement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085136
active diarrhea
Descrizione

active diarrhea

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011991
known history of coagulation disorder
Descrizione

coagulation disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005779
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
Descrizione

cytochrome p450 3a4

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3830625
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
Descrizione

ketoconazole

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022625
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
Descrizione

chemotherapy, immunotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083

Similar models

Eligibility Advanced Solid Tumors NCT00520637

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
solid tumor or lymphoma
Item
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
ecog
Item
score of 0 to 2 on the ecog performance scale
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
medical illness
Item
concurrent serious medical illness
boolean
C0262926 (UMLS CUI [1])
central nervous system (cns) tumor involvement
Item
known, clinically suspected, or history of central nervous system (cns) tumor involvement
boolean
C0085136 (UMLS CUI [1])
active diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
coagulation disorder
Item
known history of coagulation disorder
boolean
C0005779 (UMLS CUI [1])
cytochrome p450 3a4
Item
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
boolean
C3830625 (UMLS CUI [1])
ketoconazole
Item
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
boolean
C0022625 (UMLS CUI [1])
chemotherapy, immunotherapy
Item
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial